{"id":68,"date":"2026-11-06T09:06:25","date_gmt":"2026-11-06T09:06:25","guid":{"rendered":"https:\/\/healthcare.hibisports.com\/?p=68"},"modified":"2026-11-06T09:06:25","modified_gmt":"2026-11-06T09:06:25","slug":"a-new-pancreatic-cancer-drug-could-buy-patients-more-time","status":"publish","type":"post","link":"https:\/\/healthcare.hibisports.com\/?p=68","title":{"rendered":"A New Pancreatic Cancer Drug Could Buy Patients More Time"},"content":{"rendered":"<div id=\"health-sc-page_1-0\" class=\"comp health-sc-page mntl-sc-page mntl-block structured-content article-content expert-content right-rail__offset lock-journey\" data-sc-sticky-offset=\"60\" data-sc-ad-label-height=\"24\" data-sc-ad-track-spacing=\"100\" data-sc-min-track-height=\"250\" data-sc-max-track-height=\"600\" data-sc-breakpoint=\"50em\" data-sc-load-immediate=\"4\" data-sc-content-positions=\"[400, 1400, 1400, 1700, 2000, 2200, 2400, 2600, 2800]\" data-bind-scroll-on-start=\"true\">\n<div id=\"health-sc-block-callout--key-takeaway_1-0\" class=\"comp health-sc-block-callout--key-takeaway health-sc-block-callout-base mntl-sc-block-callout mntl-block theme-key-takeaway theme-key-takeaway\" data-tracking-id=\"mntl-sc-block-callout\" data-tracking-container=\"true\">\n<h3 id=\"mntl-sc-block-callout-heading_1-0\" class=\"comp mntl-sc-block-callout-heading mntl-text-block\">Key Takeaways<\/h3>\n<div id=\"mntl-sc-block-callout-body_1-0\" class=\"comp mntl-sc-block-callout-body mntl-text-block expert-content\">\n<ul>\n<li>Rasonque is a new FDA-approved medication for advanced pancreatic cancer.<\/li>\n<li>The daily pill targets RAS mutations and offers a new option for people whose cancer has progressed after prior treatment.<\/li>\n<li>Rasonque doubled survival time compared with chemotherapy in a clinical trial of people with advanced pancreatic cancer.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<p id=\"mntl-sc-block_2-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> The Food and Drug Administration (FDA) recently approved the breakthrough pancreatic cancer treatment Rasonque (daraxonrasib). This daily pill helps people live twice as long as they would with chemotherapy, according to a recent phase 3 clinical trial.<span data-cite=\"1\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_3-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_4-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> Daraxonrasib targets the RAS gene mutation that causes pancreatic cancer cell growth.<span data-cite=\"2\" class=\"inline-citation-node\"><\/span> This drug is now available for people with metastatic pancreatic adenocarcinoma, the most common type of pancreatic cancer, who have received prior therapies and otherwise have limited treatment options.<span data-cite=\"9\" class=\"inline-citation-node\"><\/span><span data-cite=\"10\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_5-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p><span class=\"heading-toc\" id=\"toc-rasonque-doubled-survival-time-compared-with-chemotherapy\"><\/span><\/p>\n<h2 id=\"mntl-sc-block_6-0\" class=\"comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading\"> <span class=\"mntl-sc-block-heading__text text-title-300\"> Rasonque Doubled Survival Time Compared With Chemotherapy <\/span> <\/h2>\n<p id=\"mntl-sc-block_7-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> The phase 3 clinical trial included 500 participants who were given daraxonrasib or chemotherapy. On average, people given daraxonrasib survived 13.2 months, while those on chemotherapy survived 6.7 months.<span data-cite=\"1\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_8-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\">\n<div id=\"mm-ads-native_1-0\" class=\"comp mm-ads-native \" style=\"--native-ad-height: auto\" data-right-rail-index=\"1\">\n<div id=\"mm-ads-native__adunit_1-0\" class=\"comp mm-ads-native__adunit mm-ads-gpt-dynamic-adunit mm-ads-gpt-adunit scads-to-load gpt native js-immediate-ad js-immediate-ad-loaded\">\n<div id=\"native\" class=\"wrapper\" data-type=\"native\" data-pos=\"native\" data-priority=\"4\" data-sizes=\"[[1, 3],&quot;fluid&quot;]\" data-rtb=\"false\" data-wait-for-third-party=\"false\" data-targeting=\"{}\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<p id=\"mntl-sc-block_9-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> The findings received a standing ovation when they were presented at the American Society of Clinical Oncology (ASCO) conference on May 31, 2026.<span data-cite=\"4\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_10-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_11-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> People taking this drug not only live longer but can also avoid debilitating side effects\u2014such as severe nerve damage and hair loss\u2014that come with chemotherapy, according to <a class=\"\" href=\"https:\/\/www.getcare.hackensackmeridianhealth.org\/provider\/tracy-a-proverbs-singh\/1314585\" data-type=\"\" data-component=\"link\" data-source=\"inlineLink\" data-ordinal=\"1\" rel=\"noopener noreferrer\" target=\"_blank\">Tracy Proverbs-Singh, MD<\/a>, a gastrointestinal medical oncologist at the John Theurer Cancer Center, Hackensack Meridian Health, in New Jersey.\n<\/p>\n<div id=\"mntl-sc-block_12-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_13-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> \u201cThe approval of daraxonrasib is arguably the most significant and hopeful development I have witnessed, fundamentally reshaping the outlook for my patients,\u201d she told<em> <\/em>Verywell in an email.\n<\/p>\n<div id=\"mntl-sc-block_14-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_15-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> Most trial participants tolerated the drug well. Common side effects of daraxonrasib include nausea, rash, diarrhea, swelling, bleeding, or loss of appetite.<span data-cite=\"13\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_16-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_17-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> \u201cThe most serious risk identified is a <a class=\"recommendation-inline-link-ai\" href=\"https:\/\/www.verywellhealth.com\/radiation-pneumonitis-symptoms-and-treatment-2249341\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"internalLink\" data-ordinal=\"1\" rel=\"noopener noreferrer\">rare but potentially fatal lung inflammation<\/a> known as pneumonitis, but overall, the drug\u2019s tolerability is a key advantage, allowing patients to stay on the life-extending treatment longer,\u201d Proverbs-Singh said.\n<\/p>\n<div id=\"mntl-sc-block_18-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<div id=\"health-sc-block-spotlight--mid-circ_1-0\" class=\"comp health-sc-block-spotlight--mid-circ mntl-sc-block-spotlight--mid-circ mntl-block theme-mid-circ theme-mid-circ\" data-use-proximity=\"true\">\n<h2 id=\"midcirc__heading_1-0\" class=\"comp midcirc__heading mntl-text-block\">Related Stories<\/h2>\n<div id=\"midcirc__card-list_1-0\" class=\"comp midcirc__card-list mntl-block\"><a href=\"https:\/\/www.verywellhealth.com\/glp-1-drugs-blood-pressure-11979086\" rel=\"nocaes\" data-card-index=\"0\" data-click-tracked=\"false\" id=\"midcirc-card_1-0\" class=\"midcirc-card mntl-midcirc-card mntl-text-link \" data-tracking-container=\"true\"><\/p>\n<div id=\"midcirc-card__title_1-0\" class=\"comp midcirc-card__title mntl-text-block\">New Research Shows GLP-1 Drugs May Help Reduce Blood Pressure<\/div>\n<div id=\"midcirc-card__image-wrapper_1-0\" class=\"comp midcirc-card__image-wrapper mntl-block\">\n<div class=\"midcirc-card__image mntl-image card__media universal-image__container\">\n<div class=\"img-placeholder\" style=\"padding-bottom:66.6%;\">\n<img data-src=\"https:\/\/www.verywellhealth.com\/thmb\/JA6dov_zpWD161B-RfXeeqgylIY=\/300x200\/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)\/VWH-GettyImages-2277072224-253694d5d5264cc6b2ba7d55e3d92845.jpg\" width=\"300\" height=\"200\" alt=\"Table with medicine blister packs water glass and GLP-1\" class=\" universal-image__image lazyloadwait\"><br \/>\n<noscript><br \/>\n<img\nsrc=\"https:\/\/www.verywellhealth.com\/thmb\/JA6dov_zpWD161B-RfXeeqgylIY=\/300x200\/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)\/VWH-GettyImages-2277072224-253694d5d5264cc6b2ba7d55e3d92845.jpg\"\nwidth=\"300\"\nheight=\"200\"\nclass=\"img--noscript universal-image__image\"\nalt=\"Table with medicine blister packs water glass and GLP-1\"\n\/><br \/>\n<\/noscript>\n<\/div>\n<\/div>\n<\/div>\n<p><\/a><br \/>\n<a href=\"https:\/\/www.verywellhealth.com\/jemperli-fda-approval-12184310\" rel=\"nocaes\" data-card-index=\"1\" data-click-tracked=\"false\" id=\"midcirc-card_2-0\" class=\"midcirc-card mntl-midcirc-card mntl-text-link \" data-tracking-container=\"true\"><\/p>\n<div id=\"midcirc-card__title_2-0\" class=\"comp midcirc-card__title mntl-text-block\">FDA Accelerates Approval of a Rectal Cancer Drug That Could Make Treatment Easier<\/div>\n<div id=\"midcirc-card__image-wrapper_2-0\" class=\"comp midcirc-card__image-wrapper mntl-block\">\n<div class=\"midcirc-card__image mntl-image card__media universal-image__container\">\n<div class=\"img-placeholder\" style=\"padding-bottom:66.6%;\">\n<img data-src=\"https:\/\/www.verywellhealth.com\/thmb\/dvrjiNHyWm6sjk6_Injm5GzQp2U=\/300x200\/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)\/VWH-GettyImages-645011548-a1d7be3e7bbc467db4a7b0070982eb8a.jpg\" width=\"300\" height=\"200\" alt=\"A persons arm with an IV line and a wristband resting on a hospital bed pillow\" class=\" universal-image__image lazyloadwait\"><br \/>\n<noscript><br \/>\n<img\nsrc=\"https:\/\/www.verywellhealth.com\/thmb\/dvrjiNHyWm6sjk6_Injm5GzQp2U=\/300x200\/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)\/VWH-GettyImages-645011548-a1d7be3e7bbc467db4a7b0070982eb8a.jpg\"\nwidth=\"300\"\nheight=\"200\"\nclass=\"img--noscript universal-image__image\"\nalt=\"A persons arm with an IV line and a wristband resting on a hospital bed pillow\"\n\/><br \/>\n<\/noscript>\n<\/div>\n<\/div>\n<\/div>\n<p><\/a><\/div>\n<\/div>\n<div id=\"mntl-sc-block_20-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p><span class=\"heading-toc\" id=\"toc-rasonque-offers-hope-for-advanced-pancreatic-cancer\"><\/span><\/p>\n<h2 id=\"mntl-sc-block_21-0\" class=\"comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading\"> <span class=\"mntl-sc-block-heading__text text-title-300\"> Rasonque Offers Hope for Advanced Pancreatic Cancer <\/span> <\/h2>\n<p id=\"mntl-sc-block_22-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> Most people with <a class=\"recommendation-inline-link\" href=\"https:\/\/www.verywellhealth.com\/pancreatic-cancer-7371535\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"internalLink\" data-ordinal=\"1\" rel=\"noopener noreferrer\">pancreatic cancer<\/a> are diagnosed only after it has metastasized, or spread to other parts of the body.<span data-cite=\"5\" class=\"inline-citation-node\"><\/span> At this advanced stage, pancreatic cancer is hard to treat: On average, people who are diagnosed with <a href=\"https:\/\/www.verywellhealth.com\/stage-4-pancreatic-cancer-survival-rates-5113942\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"internalLink\" data-ordinal=\"2\">stage 4 pancreatic cancer have a five-year survival rate of 3%<\/a>.<span data-cite=\"14\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_23-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_24-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> \u201cMost patients with metastatic pancreatic cancer receive <a class=\"recommendation-inline-link-ai\" href=\"https:\/\/www.verywellhealth.com\/what-is-combination-chemotherapy-2248995\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"internalLink\" data-ordinal=\"1\" rel=\"noopener noreferrer\">combination chemotherapy<\/a> as their initial treatment. Until now, patients whose cancer progressed often had another chemotherapy regimen as their next option,\u201d said <a class=\"\" href=\"https:\/\/www.cityofhope.org\/patients\/find-a-doctor\/pashtoon-kasi\" data-type=\"\" data-component=\"link\" data-source=\"inlineLink\" data-ordinal=\"2\" rel=\"noopener noreferrer\" target=\"_blank\">Pashtoon Kasi, MD<\/a>, an associate clinical professor and medical director of GI Medical Oncology at City of Hope Orange County, Irvine, California.\n<\/p>\n<div id=\"mntl-sc-block_25-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_26-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> Daraxonrasib offers these individuals a promising second-line treatment option. The pill targets cancer-causing<em> RAS<\/em> genetic mutations found in over 90% of people with pancreatic cancer.<span data-cite=\"1\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_27-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_28-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> \u201cRAS was once viewed as essentially \u2018undruggable.\u2019 We are now entering an era in which we can directly target a major biological driver of pancreatic cancer. That opens the door not only to using daraxonrasib today, but also to studying it earlier in treatment and in new combinations that may help us continue improving outcomes,\u201d Kasi told <em>Verywell <\/em>in an email.\n<\/p>\n<div id=\"mntl-sc-block_29-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p><span class=\"heading-toc\" id=\"toc-rasonque-could-treat-other-ras-driven-cancers\"><\/span><\/p>\n<h2 id=\"mntl-sc-block_30-0\" class=\"comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading\"> <span class=\"mntl-sc-block-heading__text text-title-300\"> Rasonque Could Treat Other RAS-Driven Cancers <\/span> <\/h2>\n<p id=\"mntl-sc-block_31-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> Future studies will show if this treatment works for other <em>RAS<\/em>-mutation cancers, like colorectal cancer and non-small cell lung cancer.<span data-cite=\"7\" class=\"inline-citation-node\"><\/span> A phase 3 trial is also underway to test whether daraxonrasib or a combination of daraxonrasib and chemotherapy is effective as a first-line treatment.<span data-cite=\"11\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<div id=\"mntl-sc-block_32-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_33-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> \u201cThe drug\u2019s novel \u2018pan-RAS\u2019 mechanism, which targets a wide array of cancer-causing mutations, represents a new class of therapy, with its manufacturer, Revolution Medicines, developing a pipeline of similar drugs,\u201d Proverbs-Singh said.\n<\/p>\n<div id=\"mntl-sc-block_34-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_35-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> For now this drug is only available for adults with metastatic pancreatic adenocarcinoma who have received chemotherapy or can\u2019t take combination chemotherapy. It may take four to six weeks for patients to receive the pills after their physician\u2019s application is approved, Proverbs-Singh added. A 30-day supply costs $39,800 without insurance.\n<\/p>\n<div id=\"mntl-sc-block_36-0\" class=\"comp mntl-sc-block mntl-sc-block-adslot mntl-block\"><\/div>\n<p id=\"mntl-sc-block_37-0\" class=\"comp mntl-sc-block mntl-sc-block-html\"> \u201cEligible patients can access the drug now, though not through a standard prescription,\u201d Proverbs-Singh said. \u201cInstead, it is available through a special FDA-authorized Expanded Access Program (EAP), which requires the patient\u2019s physician to apply directly to the manufacturer.\u201d<span data-cite=\"12\" class=\"inline-citation-node\"><\/span>\n<\/p>\n<\/div>\n<div id=\"post-article_1-0\" class=\"comp post-article mntl-block\">\n<div id=\"breadcrumbs--chips_1-0\" class=\"comp breadcrumbs--chips mntl-universal-breadcrumbs--chips mntl-block\">\n<div id=\"mntl-breadcrumbs__read-more_1-0\" class=\"comp mntl-breadcrumbs__read-more mntl-text-block text-title-100\">Read More:<\/div>\n<ul id=\"mntl-universal-breadcrumbs_1-0\" class=\"comp mntl-universal-breadcrumbs mntl-block breadcrumbs\" data-tracking-container=\"true\">\n<li id=\"mntl-breadcrumbs__item_1-0\" class=\"comp mntl-breadcrumbs__item mntl-block text-utility-200\"><a href=\"https:\/\/www.verywellhealth.com\/prevention-and-treatment-4158390\" rel=\"nocaes\" class=\"mntl-text-link mntl-breadcrumbs__link\" id=\"mntl-text-link_5-0\" data-tracking-container=\"true\"><span class=\"link__wrapper\">Prevention &amp; Treatment<\/span><\/a><\/li>\n<li id=\"mntl-breadcrumbs__item_2-0\" class=\"comp mntl-breadcrumbs__item mntl-block text-utility-200\"><a href=\"https:\/\/www.verywellhealth.com\/prescription-and-otc-drugs-8640681\" rel=\"nocaes\" class=\"mntl-text-link mntl-breadcrumbs__link\" id=\"mntl-text-link_6-0\" data-tracking-container=\"true\"><span class=\"link__wrapper\">Drugs<\/span><\/a><\/li>\n<\/ul>\n<\/div>\n<div id=\"sources_1-0\" class=\"comp sources mntl-block\">\n<div id=\"mntl-article-sources_1-0\" class=\"comp mntl-article-sources mntl-expandable-block\" data-scroll-offset=\"70\">\n<div class=\"loc toggle-content\">\n<div id=\"mntl-article-sources__wrapper_1-0\" class=\"comp mntl-article-sources__wrapper mntl-block\" data-click-tracked=\"true\" tabindex=\"0\"><span id=\"mntl-article-sources__heading_1-0\" class=\"comp mntl-article-sources__heading mntl-text-block\">11 Sources<\/span><br \/>\n<svg class=\"icon show-icon \">\n<use xmlns_xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink_href=\"#show-icon\" href=\"#show-icon\"><\/use>\n<\/svg><br \/>\n<svg class=\"icon hide-icon \">\n<use xmlns_xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink_href=\"#hide-icon\" href=\"#hide-icon\"><\/use>\n<\/svg><\/div>\n<\/div>\n<div class=\"loc expandable-content\">\n<div id=\"source-guidelines_1-0\" class=\"comp source-guidelines mntl-text-block\">Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our <a href=\"\/verywell-editorial-process-4777042\">editorial process<\/a> to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.<\/div>\n<div id=\"mntl-article-sources__citation-sources_1-0\" class=\"comp mntl-article-sources__citation-sources mntl-citation-sources mntl-sources\" data-tracking-container=\"true\">\n<ol class=\"mntl-sources__content\">\n<li class=\"mntl-sources__source\" id=\"citation-1\">\n<p>O\u2019Reilly EM, Wainberg ZA, Hendifar AE, et al. <a href=\"http:\/\/doi.org\/10.1056\/NEJMoa2605555\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Daraxonrasib or chemotherapy in previously treated metastatic pancreatic cancer<\/a>. <em>N Engl J Med<\/em>. 2026;395(4):325-337. doi:10.1056\/NEJMoa2605555<\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-2\">\n<p>Memorial Sloan Kettering Cancer Center. <a href=\"https:\/\/www.mskcc.org\/news\/how-daraxonrasib-could-improve-pancreatic-cancer-treatment-offering-new-hope\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">FDA approves daraxonrasib for pancreatic cancer: what patients need to know<\/a>.<\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-9\">\n<p>Johns Hopkins Medicine. <a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/pancreatic-cancer\/pancreatic-cancer-types\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Pancreatic cancer types.<\/a><\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-10\">\n<p>Food and Drug Administration. <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-daraxonrasib-metastatic-pancreatic-adenocarcinoma\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">FDA approves daraxonrasib for metastatic pancreatic adenocarcinoma.<\/a><\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-4\">\n<p>Thornton J. <a href=\"https:\/\/www.bmj.com\/content\/393\/bmj-2026-902114\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Pancreatic cancer: new drug results prompt standing ovation at oncology conference.<\/a> <em>BMJ<\/em>. 2026;393:e902114. doi:10.1136\/bmj-2026-902114<\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-13\">\n<p>Wolpin BM, Park W, Garrido-Laguna I, et al. <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2505783\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Daraxonrasib in previously treated advanced&nbsp;<em>RAS<\/em>-mutated pancreatic cancer.<\/a>&nbsp;<em>N Engl J Med<\/em>. 2026;394(18):1790-1802. doi:10.1056\/NEJMoa2505783<\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-5\">\n<p>Pancreatic Cancer Action Network. <a href=\"https:\/\/pancan.org\/facing-pancreatic-cancer\/living-with-pancreatic-cancer\/advanced-cancer\/#whatisadvancedcancer\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Advanced pancreatic cancer<\/a>.<\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-14\">\n<p>American Cancer Society. <a href=\"https:\/\/www.cancer.org\/cancer\/types\/pancreatic-cancer\/detection-diagnosis-staging\/survival-rates.html\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Survival rates for pancreatic cancer.<\/a><\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-7\">\n<p>National Library of Medicine. <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06881784\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Study of daraxonrasib (RMC-6236) in patients with RAS mutated NSCLC (RASolve 301) (RASolve 301)<\/a>.<\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-11\">\n<p>National Cancer Institute. <a href=\"https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2026-03710\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Study of daraxonrasib and daraxonrasib + GnP as first-line treatment in patients with metastatic pancreatic adenocarcinoma.<\/a><\/p>\n<\/li>\n<li class=\"mntl-sources__source\" id=\"citation-12\">\n<p>Food and Drug Administration. <a href=\"https:\/\/www.fda.gov\/news-events\/public-health-focus\/expanded-access\" data-component=\"link\" data-source=\"inlineLink\" data-type=\"externalLink\" data-ordinal=\"1\" target=\"_blank\" rel=\"noopener\">Expanded access.<\/a><\/p>\n<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"author-bio_1-0\" class=\"comp author-bio\">\n<div class=\"loc author-bio__image\">\n<img data-src=\"https:\/\/www.verywellhealth.com\/thmb\/hEZrL73FFGkN98J34JAaeHp5A2Q=\/144x144\/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)\/StephanieBrownnewheadshot-e5ca9ba2a404491384e9300a7871f190.jpg\" width=\"144\" height=\"144\" alt=\"Stephanie Brown\" class=\" author-bio__image mntl-image universal-image__image lazyloadwait\" data-expand=\"300\"><br \/>\n<noscript><br \/>\n<img\nsrc=\"https:\/\/www.verywellhealth.com\/thmb\/hEZrL73FFGkN98J34JAaeHp5A2Q=\/144x144\/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)\/StephanieBrownnewheadshot-e5ca9ba2a404491384e9300a7871f190.jpg\"\nwidth=\"144\"\nheight=\"144\"\nclass=\"img--noscript author-bio__image mntl-image universal-image__image\"\nalt=\"Stephanie Brown\"\n\/><br \/>\n<\/noscript>\n<\/div>\n<p class=\"author-bio__bio-text\">\n<span class=\"author-bio__bio-title\">By <a href=\"https:\/\/www.verywellhealth.com\/stephanie-brown-5197949\">Stephanie Brown<\/a><\/span><br \/>\n<br \/>\nBrown is a nutrition writer who received her Didactic Program in Dietetics certification from the University of Tennessee at Knoxville. Previously, she worked as a nutrition educator and culinary instructor in New York City.\n<\/p>\n<\/div>\n<div id=\"trust-ribbon_1-0\" class=\"comp trust-ribbon trust-ribbon-expandable-block\">\n<div class=\"content-wrapper\">\n<div class=\"loc static-content\">\n<div id=\"trust-ribbon__editorial_1-0\" class=\"comp trust-ribbon__editorial trust-ribbon-item mntl-block\"><svg class=\"icon trust-ribbon-item__icon-editorial \">\n<use xmlns_xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink_href=\"#trust-ribbon-item__icon-editorial\" href=\"#trust-ribbon-item__icon-editorial\"><\/use>\n<\/svg><br \/>\n<a href=\"\/verywell-editorial-process-4777042\" rel=\"nocaes\" class=\"trust-ribbon-item__text mntl-text-link \" id=\"trust-ribbon-item__text_1-0\" data-tracking-container=\"true\"><span class=\"link__wrapper\">See Our Editorial Process<\/span><\/a><\/div>\n<div id=\"trust-ribbon__review_1-0\" class=\"comp trust-ribbon__review trust-ribbon-item mntl-block\"><svg class=\"icon reviewer-icon trust-ribbon-item__icon-review\">\n<use xmlns_xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink_href=\"#reviewer-icon\" href=\"#reviewer-icon\"><\/use>\n<\/svg><br \/>\n<a href=\"\/meet-our-medical-expert-board-11762003\" rel=\"nocaes\" class=\"trust-ribbon-item__text mntl-text-link \" id=\"trust-ribbon-item__text_2-0\" data-tracking-container=\"true\"><span class=\"link__wrapper\">Meet Our Medical Expert Board<\/span><\/a><\/div>\n<\/div>\n<div class=\"loc toggle-content\">\n<div id=\"trust-ribbon__feedback_1-0\" class=\"comp trust-ribbon__feedback trust-ribbon-item mntl-block\"><svg class=\"icon trust-ribbon-item__icon-feedback \">\n<use xmlns_xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink_href=\"#trust-ribbon-item__icon-feedback\" href=\"#trust-ribbon-item__icon-feedback\"><\/use>\n<\/svg><br \/>\n<button id=\"trust-ribbon-item__text_3-0\" class=\"comp trust-ribbon-item__text mntl-text-block\">Share Feedback<\/button><\/div>\n<\/div><\/div>\n<div class=\"loc expandable-content\">\n<div id=\"trust-ribbon__feedback-block_1-0\" class=\"comp trust-ribbon__feedback-block article-feedback mntl-article-feedback\">\n<div class=\"article-feedback__rating-section js-rating-section is-hidden\">\n<div class=\"article-feedback__heading\">Was this page helpful?<\/div>\n<\/div>\n<div class=\"article-feedback__success-section js-success-section is-hidden\">\n<div class=\"article-feedback__heading\">Thanks for your feedback!<\/div>\n<\/div>\n<div class=\"article-feedback__feedback-section js-feedback-section\">\n<div class=\"article-feedback__heading\">What is your feedback?<\/div>\n<p><button id=\"helpful-button_1-0\" class=\"comp helpful-button mntl-button article-feedback__feedback-button\"> Helpful<br \/>\n<\/button><br \/>\n<button id=\"report-error-button_1-0\" class=\"comp report-error-button mntl-button article-feedback__feedback-button\"> Report an Error<br \/>\n<\/button><br \/>\n<button id=\"other-button_1-0\" class=\"comp other-button mntl-button article-feedback__feedback-button\"> Other<br \/>\n<\/button><br \/>\n<svg class=\"icon icon-x close-button\">\n<use xmlns_xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink_href=\"#icon-x\" href=\"#icon-x\"><\/use>\n<\/svg> <\/p>\n<form action=\"\/ugc-feedback\" method=\"post\" class=\"article-feedback__feedback-form js-feedback-form\">\n<textarea class=\"article-feedback__feedback-text js-feedback-text\" placeholder=\"Tell us more...\" required=\"required\" maxlength=\"1500\"><\/textarea><br \/>\n<button id=\"article-feedback__submit-button_1-0\" class=\"comp article-feedback__submit-button mntl-button\"> Submit<br \/>\n<\/button> <input type=\"hidden\" name=\"doc-id\" value=\"12069924\" class=\"js-doc-id\"><br \/>\n<\/form>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Rasonque is a new FDA-approved medication for advanced pancreatic cancer. The daily pill targets RAS mutations and offers a new option for people whose cancer has progressed after prior treatment. Rasonque doubled survival time compared with chemotherapy in&#8230; <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-68","post","type-post","status-publish","format-standard","hentry","category-chua-phan-loai"],"_links":{"self":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/posts\/68","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=68"}],"version-history":[{"count":0,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/posts\/68\/revisions"}],"wp:attachment":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=68"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=68"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=68"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}